Literature DB >> 28283114

The varieties of psychosis in multiple sclerosis: A systematic review of cases.

Carlos R Camara-Lemarroy1, Beatriz E Ibarra-Yruegas2, Rene Rodriguez-Gutierrez3, Idanis Berrios-Morales4, Carolina Ionete4, Peter Riskind4.   

Abstract

OBJECTIVES: Multiple Sclerosis (MS) is known to be associated with a wide range of psychiatric symptoms, particularly with affective disorders. However, a link to psychotic disorders has not been fully established.
METHODS: A systematic review of the PubMed/MEDLINE database was performed to identify cases of MS presenting with psychotic symptoms. Variables analyzed included patient demographics, clinical presentation, imaging characteristics and treatment.
RESULTS: Ninety-one cases were identified. The mean age was 34.4, and there was a female predominance. The majority of patients did not have a prior history of MS or psychiatric disease. The majority of cases could be classified as having either Psychotic Disorders or Mood Disorders with psychotic features. Most patients received some type of antipsychotic therapy, with variable success. At least 26 patients were treated with corticosteroids in the acute phase of their psychotic symptoms, and the majority responded favorably. Imaging data was available for 50 patients. Of these, 60% had predominantly fronto-temporal lesions, and most had contrast enhancing lesions.
CONCLUSIONS: MS can present with a variety of psychotic symptoms. The presence of enhancing lesions and steroid-responsiveness suggests these could be characterized as flares.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Multiple Sclerosis; Psychiatric manifestations; Psychosis; Schizophrenia

Mesh:

Year:  2016        PMID: 28283114     DOI: 10.1016/j.msard.2016.12.012

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  8 in total

Review 1.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

Review 2.  Multiple Sclerosis and Schizophrenia.

Authors:  Borros M Arneth
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

3.  First-episode psychosis as the initial presentation of multiple sclerosis: a case report.

Authors:  Athena Enderami; Rose Fouladi; Seyed Hamzeh Hosseini
Journal:  Int Med Case Rep J       Date:  2018-04-05

Review 4.  A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis.

Authors:  Souhel Najjar; Johann Steiner; Amanda Najjar; Karl Bechter
Journal:  J Neuroinflammation       Date:  2018-02-13       Impact factor: 8.322

5.  Cerebrospinal fluid findings in patients with psychotic symptoms-a retrospective analysis.

Authors:  Tim W Rattay; Pascal Martin; Debora Vittore; Holger Hengel; Idil Cebi; Johannes Tünnerhoff; Maria-Ioanna Stefanou; Jonatan F Hoffmann; Katrin von der Ehe; Johannes Klaus; Julia Vonderschmitt; Matthias L Herrmann; Paula Bombach; Hazar Al Barazi; Lena Zeltner; Janina Richter; Klaus Hesse; Kathrin N Eckstein; Stefan Klingberg; Dirk Wildgruber
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

6.  Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: A consultation-liaison psychiatry service's experience.

Authors:  Yuko Yagi; Yusuke Takahashi; Yu Ogata; Hayato Yamana; Yousuke Kumakura; Kayo Ichihashi; Kiyoto Kasai; Shinsuke Kondo
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-31

7.  Microglia-derived CCL2 has a prime role in neocortex neuroinflammation.

Authors:  Mariella Errede; Tiziana Annese; Nicole Kerlero de Rosbo; Daniela Virgintino; Valentina Petrosino; Giovanna Longo; Francesco Girolamo; Ignazio de Trizio; Antonio d'Amati; Antonio Uccelli
Journal:  Fluids Barriers CNS       Date:  2022-08-30

8.  [Acute psychotic episode as a primary clinical manifestation of multiple sclerosis-a case report].

Authors:  Sharmili Edwin Thanarajah; Hannah Wendy; Andreas Reif; Christine Reif-Leonhard
Journal:  Nervenarzt       Date:  2021-03-24       Impact factor: 1.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.